Global Nasal Stent Market Size By Type (Disposable, Reusable), By Application (Hospitals, Ambulatory Settings), By Region, And Segment Forecasts, 2023 to 2032

The Global Nasal Stent Market was valued at USD 980 million in 2023 and is projected to reach USD 1.64 billion by 2031, growing at a compound annual growth rate (CAGR) of 6.7% during the forecast period from 2023 to 2031. The market is driven by increasing cases of chronic sinusitis, rising demand for minimally invasive ENT procedures, and technological advancements in stent materials and design. Nasal stents are used post-surgery to maintain patency, reduce bleeding, and prevent synechiae formation, significantly enhancing surgical outcomes and patient recovery.

Drivers:

1. Rising Prevalence of Chronic Rhinosinusitis:

Chronic sinusitis affects millions globally, contributing to an increased demand for ENT interventions. Nasal stents play a crucial role in post-operative care, aiding in healing and reducing complications.

2. Surge in Minimally Invasive Surgeries:

The growing preference for less invasive procedures, particularly Functional Endoscopic Sinus Surgery (FESS), has led to higher adoption of nasal stents that support tissue healing and reduce patient discomfort.

3. Advancements in Stent Technology:

Innovation in bioresorbable stents and drug-eluting variants is expanding clinical utility. These next-gen stents minimize revision surgeries and post-operative complications.

Restraints:

1. High Cost of Advanced Stents:

Premium stent products, especially drug-eluting and biodegradable types, entail high production and retail costs, limiting accessibility in price-sensitive markets.

2. Risk of Stent Displacement and Infection:

Improper placement or patient-specific anatomical challenges can lead to dislodgement or infection, discouraging adoption in certain medical settings.

Opportunity:

1. Untapped Potential in Emerging Economies:

Countries in Asia-Pacific and Latin America offer untapped market potential due to growing healthcare infrastructure, rising ENT procedural volume, and increasing awareness about post-surgical care.

2. Expansion of ENT Specialty Clinics:

The global proliferation of ENT-focused outpatient centers boosts demand for specialized tools like nasal stents, especially those that improve post-operative outcomes.

Market by System Type Insights:

The Drug-Eluting Nasal Stent segment held the largest market share in 2023. These stents offer the dual benefit of structural support and localized drug delivery (e.g., corticosteroids), improving healing rates and reducing inflammation. Meanwhile, Bioresorbable Nasal Stents are projected to witness the fastest growth owing to their ability to naturally degrade, eliminating the need for removal procedures and enhancing patient comfort.

Market by End-use Insights:

In terms of end-use, Hospitals emerged as the leading segment, accounting for over 50% of global revenue in 2023. Hospitals are the primary centers for complex ENT surgeries requiring advanced post-operative tools like nasal stents. Ambulatory Surgical Centers (ASCs) are expected to register notable growth during the forecast period due to rising adoption of same-day ENT procedures and cost-effective surgical care.

Market by Regional Insights:

North America led the global nasal stent market in 2023, driven by a high incidence of sinusitis, favorable reimbursement policies, and strong presence of key medical device companies. Asia-Pacific is forecasted to experience the highest CAGR through 2031 due to increasing healthcare spending, rising ENT surgeries, and expanding patient base in countries like China and India.

Competitive Scenario:

Prominent players in the Global Nasal Stent Market include Medtronic plc, Stryker Corporation, Intersect ENT (acquired by Medtronic), Olympus Corporation, Cook Medical, Boston Scientific, Meril Life Sciences, and Dalent Medical. These companies are focusing on product innovation, strategic collaborations, and geographical expansion.

Key Developments:

In 2023, Medtronic launched a new drug-eluting nasal stent with extended drug delivery duration.

In 2024, Olympus Corporation expanded its ENT device portfolio by acquiring a mid-sized stent manufacturer.

In 2025, Intersect ENT announced clinical trial results showing improved outcomes with their second-gen bioabsorbable nasal stents.

Scope of Work – Global Nasal Stent Market

Report Metric Details

Market Size (2023) USD 980 million

Projected Market Size (2031) USD 1.64 billion

CAGR (2023–2031) 6.7%

Market Segments By System Type (Drug-Eluting, Bioresorbable, Non-drug), By End-use (Hospitals, Ambulatory Surgical Centers, ENT Clinics), By Region

Growth Drivers Rising sinusitis cases, adoption of minimally invasive ENT procedures, innovation in stent materials

Opportunities Emerging markets expansion, increasing ENT clinic network

Key Market Developments:

2023: Medtronic introduced an enhanced corticosteroid-eluting stent to reduce post-operative inflammation.

2024: Olympus Corporation invested in R&D to develop a biodegradable nasal stent line.

2025: Boston Scientific entered the ENT device space with a focus on drug-delivery stents.

FAQs:

1) What is the current market size of the Global Nasal Stent Market?

The Global Nasal Stent Market was valued at USD 980 million in 2023.

2) What is the major growth driver of the Global Nasal Stent Market?

The major driver is the increasing prevalence of chronic sinusitis and the rising preference for minimally invasive ENT surgeries.

3) Which is the largest region during the forecast period in the Global Nasal Stent Market?

North America holds the largest market share due to high healthcare spending and advanced medical infrastructure.

4) Which segment accounted for the largest market share in the Global Nasal Stent Market?

The Drug-Eluting Nasal Stent segment accounted for the largest share in 2023.

5) Who are the key market players in the Global Nasal Stent Market?

Key players include Medtronic plc, Olympus Corporation, Stryker Corporation, Boston Scientific, and Cook Medical.